URGN
UroGen Pharma Ltd
37.00$
-9.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 0.2% | 94.7% | 3.8% | 3.8% | 87.8% | 89.4% | 87.4% | 372.8% | 88.5% | – | 0.0% | – | – | – | 12.9% | 8.9% | 8.2% | 12.0% | 10.9% | 11.0% | 9.8% | 11.2% | 11.1% | 12.5% | 12.5% | 13.2% | 11.6% | 11.4% | 9.7% | 9.2% | 10.2% | 9.7% | 10.1% | 11.5% | 14.7% | 11.9% | 8.7% | 8.1% | 9.1% | 9.2% | |
| – | 99.8% | 5.3% | 96.2% | 96.2% | 12.2% | 10.6% | 12.6% | -272.8% | 11.5% | – | 100.0% | – | – | – | 87.1% | 91.1% | 91.8% | 88.0% | 89.1% | 89.0% | 90.2% | 88.8% | 88.9% | 87.5% | 87.5% | 86.8% | 88.4% | 88.6% | 90.3% | 90.8% | 89.8% | 90.3% | 89.9% | 88.5% | 85.3% | 88.1% | 91.3% | 91.9% | 90.9% | 90.8% | |
| – | 13.5% | 14,021.1% | 46.7% | 72.0% | 2,067.6% | 1,584.6% | 2,272.8% | 3,383.0% | 1,356.8% | – | 55,533.3% | – | – | – | 2,179.0% | 295.0% | 155.7% | 140.5% | 93.0% | 105.0% | 80.9% | 93.6% | 76.1% | 81.3% | 80.0% | 72.7% | 54.8% | 49.1% | 48.0% | 82.5% | 70.5% | 45.1% | 60.6% | 98.1% | 78.1% | 51.0% | 37.8% | 30.6% | 23.9% | 32.5% | |
| – | 7.0% | 4,605.3% | 29.4% | 28.1% | 1,051.1% | 1,261.7% | 2,804.1% | 3,796.1% | 1,485.4% | – | 76,527.8% | – | – | – | 6,456.5% | 637.5% | 278.2% | 296.1% | 171.1% | 190.5% | 247.0% | 157.0% | 125.5% | 118.5% | 119.6% | 142.4% | 106.4% | 104.3% | 104.3% | 145.4% | 137.6% | 114.8% | 141.9% | 172.6% | 178.4% | 136.8% | 104.0% | 101.0% | 66.9% | 93.7% | |
| – | 20.5% | 18,626.3% | 76.2% | 100.1% | 3,118.7% | 2,846.4% | 5,076.9% | 7,179.2% | 2,842.2% | – | 132,061.1% | – | – | – | 8,635.5% | 932.6% | 433.9% | 436.9% | 264.2% | 295.5% | 213.3% | 250.6% | 201.6% | 199.8% | 199.6% | 215.1% | 161.2% | 153.4% | 152.4% | 227.9% | 208.1% | 159.9% | 202.5% | 270.8% | 256.5% | 187.7% | 141.8% | 131.6% | 90.8% | 126.2% | |
| – | 79.3% | -18,621.1% | -76.2% | -3.9% | -3,106.4% | -2,835.8% | -5,064.3% | -7,451.9% | -2,842.2% | – | -131,961.1% | – | – | – | -8,548.4% | -841.5% | -342.1% | -348.9% | -175.1% | -206.5% | -123.1% | -161.9% | -112.7% | -112.4% | -112.1% | -128.2% | -72.8% | -64.7% | -62.1% | -137.1% | -118.3% | -69.6% | -112.6% | -182.3% | -171.2% | -99.7% | -50.5% | -39.8% | 0.2% | -35.3% | |
| – | 5.6% | 334.2% | 3.2% | 7.1% | 170.2% | 13.3% | 34.1% | 43.8% | 14.7% | – | 7,088.9% | – | – | – | – | – | – | – | 24.5% | 60.2% | 45.9% | 2.1% | 13.5% | 16.7% | 17.8% | 20.7% | 17.8% | 18.3% | 15.2% | 13.0% | 15.8% | 10.8% | 15.8% | 20.1% | 36.2% | 29.1% | 34.4% | 17.1% | 6.7% | 18.3% | |
| – | 73.7% | -17,984.2% | -79.4% | -3.8% | -3,078.6% | -2,782.1% | -4,952.2% | -7,255.5% | -2,792.0% | – | -124,872.2% | – | – | – | -8,427.2% | -832.6% | -340.8% | -346.5% | -198.8% | -266.2% | -168.9% | -206.9% | -160.6% | -156.1% | -155.8% | -175.6% | -113.9% | -105.0% | -94.2% | -171.6% | -152.7% | -93.6% | -141.9% | -214.5% | -202.0% | -125.2% | -70.4% | -55.6% | -12.0% | -52.0% | |
| – | 3.5% | 0.0% | 0.0% | 0.2% | 5.8% | -53.6% | 0.0% | 0.0% | 14.8% | – | -1,366.7% | – | – | – | – | – | 42.4% | 45.1% | 2.4% | 59.7% | 7.0% | 2.4% | 0.2% | 4.4% | 0.4% | 0.1% | 0.3% | 0.0% | 16.4% | 0.3% | 0.2% | 0.4% | 10.8% | 1.9% | 4.2% | -3.8% | -0.7% | -9.4% | 7.8% | -0.3% | |
| – | 70.2% | -17,984.2% | -79.4% | -3.8% | -3,078.6% | -2,782.1% | -4,952.2% | -7,255.5% | -2,806.7% | – | -124,872.2% | – | – | – | -8,427.2% | -832.6% | -383.2% | -346.5% | -201.2% | -266.2% | -175.9% | -209.3% | -160.8% | -160.5% | -156.1% | -175.7% | -114.2% | -104.9% | -110.6% | -171.9% | -152.9% | -93.9% | -152.7% | -216.5% | -206.2% | -121.3% | -69.7% | -46.3% | -19.8% | -51.7% | |
| – | 79.8% | -18,384.2% | -75.1% | -3.7% | -3,088.7% | -2,785.9% | -5,050.3% | -7,431.4% | -2,833.1% | – | -131,961.1% | – | – | – | -8,420.7% | -838.1% | -334.4% | -346.3% | -197.2% | -264.2% | -120.2% | -201.5% | -109.1% | -136.6% | -109.9% | -152.4% | -94.1% | -58.4% | -31.5% | -126.6% | -135.7% | -58.2% | -107.8% | -192.0% | -201.6% | -93.8% | -58.6% | -37.3% | -4.4% | -37.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.